PMH42 Cost-Utility Analysis of Paliperidone Palmitate Long Acting Injection(PLAI) Versus Oral Atypical Antipsychotics in Non-Adherent Schizophrenia Patients
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.341
https://www.valueinhealthjournal.com/article/S1098-3015(11)01903-6/fulltext
Title :
PMH42 Cost-Utility Analysis of Paliperidone Palmitate Long Acting Injection(PLAI) Versus Oral Atypical Antipsychotics in Non-Adherent Schizophrenia Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01903-6&doi=10.1016/j.jval.2011.08.341
First page :
A294
Section Title :
Mental Health
Open access? :
No
Section Order :
318